Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: elmatador who wrote (42987)	11/22/2008 2:41:48 AM
From: energyplay	Respond to of 217815

Much of the new parts of the biotech industry, the companies that don't have significant sales or are much more than a year away from drug approval, have some real problems. Venture capital has pulled back - very little funding, and almost no new biotech companies. The big drug companies with cash are in a great position. The very bad news may be much less biotech development.